-
-
-
-
-
-
-
Pain Therapeutics (PTIE) Appeals FDA Decision on REMOXY
-
-
-
-
-
-
-
Pain Therapeutics (PTIE) Confirms FDA Voted 14 to 3 Against Approval of REMOXY ER
-
-
-
-
-
-
-
DURECT Announces FDA Advisory Committee Meeting for REMOXY® ER
-
-
-
-
-
-
-
Near Term Approval of Durect (DRRX) REMOXY Likely as FDA Panel Deemed Unnecessary - Rodman & Renshaw
-
-
-
-
-
-
13,128 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All